A detailed history of Xtx Topco LTD transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Xtx Topco LTD holds 23,395 shares of KZIA stock, worth $39,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,395
Holding current value
$39,537
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.19 - $1.24 $4,445 - $29,009
23,395 New
23,395 $10,000
Q1 2024

May 13, 2024

SELL
$0.2 - $0.45 $189 - $427
-949 Reduced 4.88%
18,487 $5,000
Q4 2023

Feb 13, 2024

BUY
$0.39 - $0.99 $7,580 - $19,241
19,436 New
19,436 $8,000

Others Institutions Holding KZIA

About KAZIA THERAPEUTICS LTD


  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $25.5M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.